Multiple sclerosis has traditionally been described as a demylinating disorder. There is now overwhelming evidence pointing to a very significant degenerative component. Current treatment options include immunomodulating and immunosuppressive agents as well as monoclonal antibodies and target the inflammatory ...
Many areas related to the diagnosis and treatments of multiple sclerosis are being explored. These include a more in-depth analysis of genetic factors, including factors, which may help with the diagnosis and prediction of patient response to treatment options. Drugs that show promise in eliminating...
There are several treatment options for multiple sclerosis. The examples listed below are U.S. FDA-approved drugs to treat multiple sclerosis. These are known as disease-modifying therapies for MS. Disease-modifying therapies have been found through clinical trials to reduce the number of relapses,...
An Update on the Treatment Options for Multiple Sclerosis An Update on the Treatment Options for Multiple Sclerosis 新野 正明 Brain and nerve : 神経研究の進歩 64(12), 1421-1426, 2012-12 新野,正明 - 《Brain\\&\\nerve:神経研究の進歩》 被引量: 0发表: 2012年 An update on the treatment...
Current Treatment Options in Neurology Aims and scope Submit manuscript Lauren B. Krupp MD & William S. MacAllister PhD 146 Accesses 9 Citations Explore all metrics Opinion statement An increasing number of children and adolescents with multiple sclerosis (MS) are being identified and treated with...
Multiple sclerosis (MS) is a multifactorial disease and its treatment can be based on different strategies. We are presently approaching the MS problem at three different levels: (1) Developing new carrier systems for the targeted delivery of therapeutical and diagnostic agents to the sites of ...
Multiple Sclerosis: What Has MS Taught You About Yourself? 7 of 10 Multiple Sclerosis (MS): Did This Affect Your Decision To Have A Child? 8 of 10 Multiple Sclerosis (MS): Which Treatment Options Have You Tried? 9 of 10 : Current video Multiple Sclerosis (MS): Will You...
Furthermore, options for possible therapeutic intervention through the chemokine system are outlined. Clinical studies in MS patients applying this knowledge are expected soon. 展开 关键词: Chemokine Chemokinrezeptorantagonisten Multiple Sklerose Chemokine Chemokine receptor antagonist Multiple sclerosis ...
Multiple sclerosis (MS) is primarily an autoimmune disease of the central nervous system, but also encompasses prominent neurodegenerative aspects. A significant proportion of MS patients will develop neurological disability over time and up until recently treatment options have been limited. However, MS...
Multiple sclerosis: advances in understanding pathogenesis and emergence of oral treatment options. Lancet Neurol 2011;10:4-5.Robert A Bermel, Jeffrey A Cohen. (2011) Multiple sclerosis: advances in understanding pathogenesis and emergence of oral treatment options. The Lancet Neurology 10 , 4-5 ...